Product Description
Mechanisms of Action:
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Brazil | China | Pakistan | Russia | Taiwan | Ukraine
Approved Indications: None
Known Adverse Events: None
Company: Ineye Hospital of Chengdu University of Traditional Chinese Medicine
Company Location: Asia Pacific
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
ChiCTR2300077773 |
ChiCTR2300077773 | N/A |
Not yet recruiting |
Myopia |
2024-06-01 |
2023-11-21 |
Treatments |
|
ChiCTR2500096603 |
ChiCTR2500096603 | N/A |
/Completed |
Myopia |
2023-09-30 |